RGTI:NASDAQRigetti Computing, Inc. Analysis
Data as of 2026-04-28 - not real-time
$16.91
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Rigetti Computing (RGTI) is trading at $16.91, just above its computed support of $12.53 and well below the 200‑day SMA of $22.79, indicating a long‑term bearish backdrop. The 20‑day SMA ($16.16) sits slightly under the 50‑day SMA ($16.25), while the MACD line (0.50) remains above its signal (0.41), delivering a modest bullish signal amid a neutral RSI of 51. Volume is on an increasing trend, but the 30‑day volatility of 80.9% and a high beta of 3.36 flag substantial price swings. Fundamentally, the company posts negative revenue growth (‑17.9%), operating losses (‑$76.5 M EBITDA) and a price‑to‑sales ratio near 793, suggesting the current price is heavily premium to earnings. Nonetheless, the balance sheet is strong with $443 M of cash against $7.2 M of debt, and analysts assign a “buy” rating with a median target of $30.50, implying an upside of roughly 80% according to the provided upside/downside metric. The market sentiment is extremely greedy (Fear‑Greed Index 89.25), and upcoming Q1 earnings could swing sentiment further. In summary, the stock blends high technical optimism with weak fundamentals, creating a speculative play that hinges on future quantum‑computing breakthroughs and short‑term earnings momentum.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD with rising volume
- High volatility and beta increasing price risk
- Imminent earnings release could trigger sharp moves
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Analyst consensus target near $30.5 indicating ~80% upside
- Strong cash position supporting R&D and partnership opportunities
- Growing market interest in quantum‑computing applications
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strategic positioning in a nascent quantum‑computing industry
- Potential for transformative technology adoption across sectors
- Long‑term cash runway enabling sustained investment despite current losses
Key Metrics & Analysis
Financial Health
Revenue Growth-17.90%
P/E Ratio-93.4
ROE-64.27%
ROA-11.12%
Debt/Equity1.31
P/B Ratio10.3
Op. Cash Flow$-58543000
Free Cash Flow$-42190500
Industry P/E38.2
Technical Analysis
TrendBearish
RSI51.2
Support$12.53
Resistance$20.17
MA 20$16.16
MA 50$16.25
MA 200$22.79
MACDBullish
VolumeIncreasing
Fear & Greed Index89.25
Valuation
Target Price$30.58
Upside/Downside80.82%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta3.36
Volatility80.90%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.